Treatment of atopic disorders with gamma-interferon
CA 2069870 E · Owner: The Children'S Medical Center Corporation · Inventors: Geha, Raif S.; Leung, Donald Y. M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of treating patients having chronic severe allergic disorders, such , as atopic dermatitis or steroid-dependent asthma with gamma interferon is disclosed. The method involves treating patients afflicted with atopic dermatitis or steroid-dependent asthma with effective dosages of gamma interferon which reduces the clinical , severity of their disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 29, 1990 and granted August 22, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 29, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 29, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.